On occasion, situations may arise in which a poster presenter has an outside interest that could be perceived as a conflict of interest. It is our responsibility to disclose to the participants in that activity the nature of the relationship so those who may form their own judgments about the presentation.
Each presenter shall disclose any real or perceived relationships that are pertinent to the subject matter and could potentially be interpreted as biasing a presentation. Relationships that must be disclosed include, but are not limited to:
- Service as a paid or non-paid consultant or employee;
- Significant personal holdings in any commercial entity that provides financial support for this CME activity, or products or services related to the subject matter;
- Receipt of financial support from a commercial firm or other source;
- Research or institutional support.
Duty to Disclose
Each presenter shall disclose any real or perceived relationships that are pertinent to the subject matter and could potentially be interpreted as biasing a presentation. In addition, poster presenters must disclose “off label” uses of substances or products included in the presentation that are not approved in the United States and/or the status of substances or products that are being investigated for such use. Relationships that must be disclosed include, but are not limited to:
- Service as a paid or nonpaid consultant or employee;
- Significant personal holdings (by the presenter and/or his/her immediate family) in any commercial entity that provides financial support for this CME activity, or products or services related to the subject matter;
- Receipt of financial support from a commercial firm or other source (consultant, research, educational grant, speakers bureau, honoraria, royalties, commissions, etc.);
- Research or institutional support.
Poster Presenter Disclosure Statement
ALL authors must complete and submit either Section A online, or if Section B is required, the entire Poster Presenter Disclosure Statement form must be downloaded, completed and submitted, in its entirety.
It is the policy of MMDA to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. All those participating in these activities are required to disclose any significant financial interest or other relationship(s) that may have a direct bearing on the subject matter. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter. (Significant financial interest or other relationships can include such things as grants or research support, employee, consultant, major stockholder, member of speakers bureau, etc.) The intent of this policy is not to prevent a presenter with a significant financial or other relationship from participating. Rather, it is intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether outside interests may reflect a possible bias in either the exposition or the conclusion(s) presented. Participant agrees to accept no payment for participation in this poster activity from any source.
Poster Presenter Disclosure Statement
ALL authors must accept and submit the appropriate sections online. It is the policy of MMDA to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs.
SECTION A
I have no financial conflict of interest or other relationship with a commercial entity in relation to this presentation. My presentation does not include discussion of “off-label” substance(s)/product(s) not approved in the United States for use under discussion or of substance(s)/product(s) that are being investigated for such use.
SECTION B: Financial and Scientific Disclosures
In order to maintain scientific balance and integrity in presentations, all disclosures will be included in on-site program materials.
SECTION C: Scientific Integrity and Commercial Support
By signature at the end of this disclosure declaration, I attest that I have carefully complied with ACCME Standards for Commercial Support and MMDA’s policies regarding content and presentation of educational material.
- Be for scientific and educational purposes only and will not promote a company’s products directly or indirectly;
- Reflect total control of content by me;
- Include no “scripting,” emphasis, or influence on content by a company or its agents;
- Adhere strictly to principles of the highest quality, scientific integrity, and selection of content;
- Be free of commercial influence or bias in my comments, audiovisuals, and handout materials;
- Use generic names of pharmaceuticals or other medical products and provide balanced views of treatment options;
- Ensure that the content of slides, reference materials, and handouts in print, electronic, or other media will not enhance the specific proprietary interests of any commercial entity;
- Ensure delivery of my presentation free of the participation of industry representatives in the session room.